Safety and Immunogenicity of COVID-19 Vaccine, Inactivated in Healthy Population Aged From 3 to 11 Years

NCT05137418 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
1000
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Sinovac Research and Development Co., Ltd.